Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
66%
Best Response
100%
Bilirubin
33%
Bilirubin Level
33%
Causes of Mortality
33%
Cell Surface Markers
33%
Differential Cell Count
33%
Early Prediction
33%
Failure Prediction
33%
Graft-versus-host Disease (GvHD)
100%
Interleukin-22 (IL-22)
33%
Interleukin-6
33%
Level Surface
33%
Lymphocyte Count
100%
Lymphocytes
33%
Mesenchymal Stem Cell Therapy
100%
Mesenchymal Stromal Cells
66%
Natural Killer Cells
33%
Patient Blood Samples
33%
Patient Selection
33%
Poor Response
33%
Promising Solutions
33%
Response to Therapy
33%
Serum Cytokine Level
33%
Steroid Resistance
33%
Success Prediction
33%
T Cells
33%
Th17 Cytokines
33%
Treatment Efficacy
33%
Medicine and Dentistry
Allogeneic Hematopoietic Stem Cell Transplantation
50%
Bilirubin
50%
Cell Surface Marker
25%
Cell Therapy
100%
Clinical Study
25%
Combination Therapy
25%
Cytokine
50%
Graft Versus Host Reaction
100%
Interleukin 6
25%
Lymphocyte
100%
Mesenchymal Stem Cell
100%
Natural Killer Cell
25%
Patient Monitoring
50%
T Cell
25%
Immunology and Microbiology
Allogeneic Hematopoietic Stem Cell Transplantation
50%
Blood Cell Count
25%
Cell Surface Marker
25%
Cytokine
50%
Graft-Versus-Host Disease
100%
Interleukin 6
25%
Lymphocyte
25%
Lymphocyte Count
100%
Mesenchymal Stem Cell
100%
Natural Killer Cell
25%
Solution and Solubility
25%
T Cell
25%
Pharmacology, Toxicology and Pharmaceutical Science
Bilirubin
100%
Cell Surface Marker
50%
Clinical Study
50%
Combination Therapy
50%
Cytokine
100%
Graft Versus Host Reaction
100%
Interleukin 6
50%